Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Lai

Showing results (31-40 of 157) with videos related to

Pageof 16
Sort By:
Digestive Diseases and Sciences|March 28, 2016
Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016Dharmesh H Kaswala, Michelle Lai, Nezam H Afdhal
F1000Research|September 2, 2014
The need for antibiotic stewardship and treatment standardization in the care of cirrhotic patients with spontaneous bacterial peritonitis - a retrospective cohort study examining the effect of ceftriaxone dosingLaura Mazer, Elliot B Tapper, Gail Piatkowski, et al.
JAMA Internal Medicine|June 2, 2015
A Decision Support Tool to Reduce Overtesting for Ceruloplasmin and Improve Adherence With Clinical GuidelinesElliot B Tapper, Neil Sengupta, Michelle Lai, et al.
Dementia (London, England)|May 1, 2023
Journey to Diagnosis of Young-Onset Dementia: A Qualitative Study of People with Young-Onset Dementia and their Family Caregivers in AustraliaMichelle Lai, Yun-Hee Jeon, Heather McKenzie, et al.
The American Journal of Medicine|August 9, 2015
Understanding and Reducing Ceruloplasmin Overuse with a Decision Support Intervention for Liver Disease EvaluationElliot B Tapper, Neil Sengupta, Michelle Lai, et al.
Journal of Addictive Diseases|May 1, 2026
Underutilization of PETH testing among patients with MASLD - retrospective, single-center evaluation of the frequency and results of phosphatidylethanol testing among patients diagnosed with metabolic dysfunction-associated liver diseaseAnnabel McLaughlin, Margot Manning, Michelle Lai, et al.
Journal of Bone and Mineral Metabolism|May 31, 2012
Time to onset of efficacy in fracture reduction with current anti-osteoporosis treatmentsCharles A Inderjeeth, Kien Chan, Kevin Kwan, et al.
International Wound Journal|December 19, 2018
Evaluation of a fluidised positioner to reduce occipital pressure injuries in intensive care patients: A pilot studyMichelle Barakat-Johnson, Michelle Lai, Amit Gefen, et al.
The American Journal of Medicine|August 20, 2013
The overuse of serum ceruloplasmin measurementElliot B Tapper, David O Rahni, Ramy Arnaout, et al.
Ostomy/Wound Management|December 6, 2018
Cultivating Incontinence-associated Dermatitis Prevention Practices in an Australian Local Health District: A Quasi-experimental StudyMichelle Barakat-Johnson, Michelle Lai, Timothy Wand, et al.
Pageof 16

Showing results (31-40 of 157) with videos related to

Sort By:
Pageof 16
Digestive Diseases and Sciences|March 28, 2016
Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016Dharmesh H Kaswala, Michelle Lai, Nezam H Afdhal
F1000Research|September 2, 2014
The need for antibiotic stewardship and treatment standardization in the care of cirrhotic patients with spontaneous bacterial peritonitis - a retrospective cohort study examining the effect of ceftriaxone dosingLaura Mazer, Elliot B Tapper, Gail Piatkowski, et al.
JAMA Internal Medicine|June 2, 2015
A Decision Support Tool to Reduce Overtesting for Ceruloplasmin and Improve Adherence With Clinical GuidelinesElliot B Tapper, Neil Sengupta, Michelle Lai, et al.
Dementia (London, England)|May 1, 2023
Journey to Diagnosis of Young-Onset Dementia: A Qualitative Study of People with Young-Onset Dementia and their Family Caregivers in AustraliaMichelle Lai, Yun-Hee Jeon, Heather McKenzie, et al.
The American Journal of Medicine|August 9, 2015
Understanding and Reducing Ceruloplasmin Overuse with a Decision Support Intervention for Liver Disease EvaluationElliot B Tapper, Neil Sengupta, Michelle Lai, et al.
Journal of Addictive Diseases|May 1, 2026
Underutilization of PETH testing among patients with MASLD - retrospective, single-center evaluation of the frequency and results of phosphatidylethanol testing among patients diagnosed with metabolic dysfunction-associated liver diseaseAnnabel McLaughlin, Margot Manning, Michelle Lai, et al.
Journal of Bone and Mineral Metabolism|May 31, 2012
Time to onset of efficacy in fracture reduction with current anti-osteoporosis treatmentsCharles A Inderjeeth, Kien Chan, Kevin Kwan, et al.
International Wound Journal|December 19, 2018
Evaluation of a fluidised positioner to reduce occipital pressure injuries in intensive care patients: A pilot studyMichelle Barakat-Johnson, Michelle Lai, Amit Gefen, et al.
The American Journal of Medicine|August 20, 2013
The overuse of serum ceruloplasmin measurementElliot B Tapper, David O Rahni, Ramy Arnaout, et al.
Ostomy/Wound Management|December 6, 2018
Cultivating Incontinence-associated Dermatitis Prevention Practices in an Australian Local Health District: A Quasi-experimental StudyMichelle Barakat-Johnson, Michelle Lai, Timothy Wand, et al.
Pageof 16